Emerging therapies for Clostridium difficile infection – focus on fidaxomicin

The epidemiology of Clostridium difficile infections (CDI) has evolved during the last decades, with an increase in the reported incidence, severity of cases, and rate of mortality and relapses. These increases have primarily affected some special populations including the elderly, patients requirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaparro-Rojas, Fredy, Mullane, Kathleen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702225/
https://www.ncbi.nlm.nih.gov/pubmed/23843696
http://dx.doi.org/10.2147/IDR.S24434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702225/
https://www.ncbi.nlm.nih.gov/pubmed/23843696
http://dx.doi.org/10.2147/IDR.S24434

Ejemplares similares